Compare Flagstar Bank NA (FLG) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flagstar Bank NA vs McKesson Corporation — how do they compare? Flagstar Bank NA trades at $15.33 (market cap $6.26B), while McKesson Corporation trades at $840 (market cap $93.23B). The key difference: McKesson Corporation is far larger — about 14.9× Flagstar Bank NA's market cap, and McKesson Corporation pays the higher dividend (0.41%). Which is the better fit depends on your goals.
| FLG | MCK | |
|---|---|---|
Market Cap | $6.26B | $93.23B |
Sector | Financials | Health |
52-Week High | $15.28 | $995.69 |
52-Week Low | $10.72 | $659.01 |
Dividend Yield | 0.27% | 0.41% |
Enterprise Value | — | $97.87B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Flagstar Bank (FLG) trades at $15.36, up 2.67% today, with a bullish technical signal from moving averages. The stock shows improving fundamentals, with two consecutive quarterly EPS beats and a positive Q1 2026 net income. The company is executing a turnaround, highlighted by a proprietary technology transformation and a credit rating upgrade. The price trades below the consensus target of $17.05, with a price-to-book ratio of 0.82 suggesting potential undervaluation.
The outlook is cautiously optimistic, supported by analyst consensus and recent profitability. Key opportunities include continued operational improvement and capital returns. Risks involve the ongoing turnaround execution, net negative cash flow, and sensitivity to interest rates. The stock presents a value proposition if the bank sustains its recovery trajectory.
MCK trades at $836.49, up 4.12% in the last session, with a neutral technical signal and strong analyst consensus. Recent earnings consistently beat expectations, with Q1 2026 EPS of $11.69 surpassing the $11.56 estimate. Revenue growth is robust, reaching $359.05B in 2025, though net margins remain thin at 1.18%. The stock is supported by positive cash flow trends and a dividend payout scheduled for July 2026.
The outlook is positive, driven by earnings momentum and a $932.83 consensus price target implying 11.5% upside. Risks include low profitability margins and high liabilities, but institutional sentiment is bullish with 80% buy ratings. Investors should weigh growth in specialty pharma against execution and regulatory pressures in the healthcare sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Flagstar Bank NA
Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
